MetaCap

Who Owns Repligen Stock?

NASDAQ: RGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

163.81-6.48 (-3.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
112.64%
Institutional holders
716
  • Institutions 95.1%
  • Insiders 4.9%
  • Public and other 0.0%

Who owns Repligen stock?

Institutional investors own about 112.6% of Repligen's shares, spread across 716 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.87% of RGEN.

The largest institutional holders are FMR, LLC (11.50%), Blackrock Inc. (8.96%) and United Capital Financial Advisors, LLC (4.36%). Together, the top 10 institutions control 47.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their RGEN positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of RGEN

Repligen top institutional holders
InstitutionShares% HeldChange
FMR, LLC7.35M11.50%+121.0%
Blackrock Inc.5.73M8.96%+6.3%
United Capital Financial Advisors, LLC2.79M4.36%-0.0%
Vanguard Capital Management LLC2.44M3.82%+1.3%
Vanguard Portfolio Management LLC2.27M3.55%-1.8%
Invesco Ltd.2.13M3.34%+53.8%
Price (T.Rowe) Associates Inc2.03M3.18%+15.9%
Massachusetts Financial Services Co.2.03M3.17%+25.5%
State Street Corporation1.85M2.89%+2.7%
Ameriprise Financial, Inc.1.69M2.64%+7.2%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of RGEN

Repligen top fund holders
FundShares% Held
iShares Trust-iShares Core S&P Mid-Cap ETF2.01M3.14%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.70M2.66%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.23M1.92%
MFS Series Trust IV-MFS Mid Cap Growth Fund1.04M1.63%
T. Rowe Price New Horizons Fund, Inc.963.03K1.51%
Fidelity Contrafund851.93K1.33%
AIM Counselor Series TRT -Invesco Discovery Fd.817.87K1.28%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund709.04K1.11%
SmallCap World Fund Inc699.73K1.09%
First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd.627.68K0.98%

Frequently asked questions

Who is the largest shareholder of Repligen?

FMR, LLC is the largest institutional shareholder of RGEN, owning 11.50% of shares outstanding (7.35M shares) as of its latest 13F filing.

What percentage of Repligen is owned by institutions?

Institutions own about 112.6% of RGEN shares and 118.4% of the public float.

How much of Repligen do insiders own?

Insiders, such as officers and directors, own about 4.87% of RGEN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related